03.10.2016
- The world’s biggest insulin producer, Novo Nordisk, has announced plans to cut 1,000 jobs in response to a challenging environment and increased competition, particularly in the US...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...
08.06.2012
- Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...
